L. Guay

J. Fagan, C. Schatschneider, D. Drotar, 1999, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children.

A. Mandalakas, P. Musoke, C. Carroll-Pankhurst, 1999, Pediatrics.

PMTCT Service Uptake Among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe

L. Guay, R. Machekano, A. Mushavi, 2017, Journal of acquired immune deficiency syndromes.

A Multi-Disciplinary Approach to Implementation Science: The NIH-PEPFAR PMTCT Implementation Science Alliance

Joan D. Nagel, L. Mofenson, D. H. Watts, 2014, Journal of acquired immune deficiency syndromes.

Facilitators and barriers to antiretroviral therapy adherence among HIV-positive adolescents living in Tanzania

G. Antelman, G. Woelk, L. Guay, 2021, BMC Public Health.

Hepatitis C virus antibody in HIV-1 infected Ugandan mothers

J. Allain, L. Guay, K. Olness, 1991, The Lancet.

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

D. Hoover, P. Musoke, T. Taha, 2005, The Journal of infectious diseases.

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

Dorothy Bray, Paul Bakaki, L. Mofenson, 2003, The Lancet.

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

L. Moulton, R. Bollinger, G. Antelman, 2008, The Lancet.

Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).

P. Musoke, L. Guay, J. Jackson, 2001, The Journal of infectious diseases.

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)

L. Mofenson, M. Fowler, P. Musoke, 2001, AIDS.

Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.

N. Parkin, S. Omer, P. Musoke, 2009, AIDS research and human retroviruses.

Characterization of Nevirapine Resistance Mutations in Women With Subtype A Vs. D HIV-1 6–8 Weeks After Single-Dose Nevirapine (HIVNET 012)

P. Musoke, L. Guay, S. Eshleman, 2004, Journal of acquired immune deficiency syndromes.

Pregnant and Postpartum Women's Experiences and Perspectives on the Acceptability and Feasibility of Copackaged Medicine for Antenatal Care and PMTCT in Lesotho

L. Guay, C. Luo, H. Hoffman, 2015, AIDS research and treatment.

Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.

S. Omer, P. Musoke, Wei Huang, 2008, The Journal of infectious diseases.

Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission.

D. Hom, L. Guay, L. Marum, 1996, Pediatrics.

Predictors of Early and Late Mother-to-Child Transmission of HIV in a Breastfeeding Population: HIV Network for Prevention Trials 012 Experience, Kampala, Uganda

M. Fowler, P. Musoke, C. Nakabiito, 2009, Journal of acquired immune deficiency syndromes.

Distinct Patterns of Emergence and Fading of K103N and Y181C in Women With Subtype A vs. D After Single-Dose Nevirapine: HIVNET 012

P. Musoke, L. Guay, J. Jackson, 2005, Journal of acquired immune deficiency syndromes.

P2‐microglobulin, HIV‐1 p24 antibody and acid‐dissociated HIV‐1 p24 antigen levels: predictive markers for vertical transmission of HIV‐1 in pregnant Ugandan women

D. Hom, L. Guay, L. Marum, 1993, AIDS.

Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants.

L. Guay, K. Olness, C. Ndugwa, 1991, AIDS.

Provision of Services and Care for HIV-Exposed Infants: A Comparison of Maternal and Child Health Clinic and HIV Comprehensive Care Clinic Models

J. Ong'ech, L. Guay, H. Hoffman, 2012, Journal of acquired immune deficiency syndromes.

Human papillomavirus prevalence and cytopathology correlation in young Ugandan women using a low‐cost liquid‐based pap preparation

J. Taube, C. Nakabiito, Y. Erozan, 2009, Diagnostic cytopathology.

Evaluating nurses' implementation of an infant-feeding counseling protocol for HIV-infected mothers: The Ban Study in Lilongwe, Malawi.

Rodney J. Knight, M. Hudgens, M. Sandelowski, 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.

Early Weaning of HIV-Exposed Uninfected Infants and Risk of Serious Gastroenteritis: Findings from Two Perinatal HIV Prevention Trials in Kampala, Uganda

S. Omer, M. Fowler, P. Musoke, 2010, Journal of acquired immune deficiency syndromes.

From research to implementation: challenges in the prevention of mother to child HIV transmission in the developing world.

L. Guay, 2001, Trends in molecular medicine.

The Cost Effectiveness of a Single‐Dose Nevirapine Regimen to Mother and Infant to Reduce Vertical HIV‐1 Transmission in Sub‐Saharan Africa

M. Fowler, P. Musoke, E. Marseille, 2000, Annals of the New York Academy of Sciences.

Proceedings of the 3rd Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2015: advancing efficient methodologies through community partnerships and team science

Alan C. Evans, Caitlin N. Dorsey, Ian M. Bennett, 2016, Implementation Science.

Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.

Linqi Zhang, M. Furtado, A. Klevytska, 2002, AIDS research and human retroviruses.

Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

Wei Huang, Christos J. Petropoulos, Susan H. Eshleman, 2007, Journal of Virology.

Co-receptor Tropism in Subtype D HIV-1 : High Prevalence of CXCR 4 Tropism and Heterogeneous Composition of Viral Populations

C. Petropoulos, E. Paxinos, N. Parkin, 2007 .

Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.

R. Shafer, L. Guay, S. Eshleman, 2002, AIDS research and human retroviruses.

Considerations in Using US-Based Laboratory Toxicity Tables to Evaluate Laboratory Toxicities Among Healthy Malawian and Ugandan Infants

M. Fowler, P. Musoke, T. Taha, 2010, Journal of acquired immune deficiency syndromes.

Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).

J. Eshleman, M. Fowler, L. Guay, 2008, AIDS research and human retroviruses.

Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival

M. Fowler, P. Musoke, D. Donnell, 2013, Journal of acquired immune deficiency syndromes.

Total Lymphocyte Count: Not a Surrogate Marker for Risk of Death in HIV-Infected Ugandan Children

L. Mofenson, M. Fowler, P. Musoke, 2008, Journal of acquired immune deficiency syndromes.

Access to HIV prevention and care for HIV-exposed and HIV-infected children: a qualitative study in rural and urban Mozambique

L. Guay, E. Bobrow, C. De Schacht, 2014, BMC Public Health.

In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.

S. Omer, F. Matovu, M. Fowler, 2009, AIDS research and human retroviruses.

Association of Antiretroviral Drug Regimen With Viral Suppression in HIV-positive Children on Antiretroviral Therapy in Eswatini.

L. Mofenson, L. Guay, R. Machekano, 2019, The Pediatric infectious disease journal.

High Rates of HIV Seroconversion in Pregnant Women and Low Reported Levels of HIV Testing among Male Partners in Southern Mozambique: Results from a Mixed Methods Study

O. Ferreira, I. Jani, L. Guay, 2014, PloS one.

The Relationship of Maternal and Child HIV Infection to Security of Attachment Among Ugandan Infants

D. Drotar, L. Guay, K. Olness, 2001, Child psychiatry and human development.

HIV‐1 ICD p24 antigen detection in Ugandan infants: Use in early diagnosis of infection and as a marker of disease progression

D. Hom, L. Guay, J. Jackson, 2000, Journal of medical virology.

Active pediatric HIV case finding in Kenya and Uganda: A look at missed opportunities along the prevention of mother-to-child transmission of HIV (PMTCT) cascade

L. Guay, H. Hoffman, M. Gill, 2020, PloS one.

Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine

P. Musoke, C. Nakabiito, D. Donnell, 2007, AIDS.

Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.

P. Musoke, C. Nakabiito, D. Donnell, 2007, The Journal of infectious diseases.

Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks?

J. Safrit, L. Mofenson, L. Guay, 2017, PloS one.

Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A.

L. Guay, J. Sierra-Madero, E. Rich, 1997, American journal of respiratory cell and molecular biology.

HIV incidence among pregnant and postpartum women in a high prevalence setting

S. Kassaye, L. Guay, V. Tukei, 2018, PloS one.

Comparison of Mother-to-Child Transmission Rates in Ugandan Women With Subtype A Versus D HIV-1 Who Received Single-Dose Nevirapine Prophylaxis: HIV Network for Prevention Trials 012

P. Musoke, L. Guay, S. Eshleman, 2005, Journal of acquired immune deficiency syndromes.

Comparison of HIV-1 Mother-to-Child Transmission After Single-Dose Nevirapine Prophylaxis Among African Women With Subtypes A, C, and D

D. Hoover, P. Musoke, T. Taha, 2006, Journal of acquired immune deficiency syndromes.

Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission

L. Mofenson, M. Fowler, P. Musoke, 2006, AIDS (London).

HIV-1 tropism and survival in vertically infected Ugandan infants.

Wei Huang, Deborah Donnell, Neil Parkin, 2008, The Journal of infectious diseases.

Safety and Efficacy of HIV Hyperimmune Globulin for Prevention of Mother-to-Child HIV Transmission in HIV-1–Infected Pregnant Women and Their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)

L. Moulton, G. Antelman, S. Omer, 2011, Journal of acquired immune deficiency syndromes.

Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1–Infected Women in Uganda (HPTN 027): The First Pediatric HIV Vaccine Trial in Africa

P. Kaleebu, N. Jones, M. Fowler, 2014, Journal of acquired immune deficiency syndromes.

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

Elliot Marseille, James G Kahn, M. Fowler, 1999, The Lancet.

Protocol to implement a syndromic surveillance survey of COVID-19 in Malawi

A. Azman, G. Woelk, M. Oziemkowska, 2022, Public Health in Practice.

Using the PMTCT Cascade to Accelerate Achievement of the Global Plan Goals

A. Goga, L. Guay, J. Ditekemena, 2017, Journal of acquired immune deficiency syndromes.

Eliminating pediatric AIDS: What it will take and what it will bring.

L. Guay, R. Simonds, 2012 .

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

W. Fawzi, D. Moodley, L. Mofenson, 2012, The Lancet.

Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to Nevirapine in developing countries

Jeffrey S. A. Stringer, James P. Hughes, J. Stringer, 2003 .

Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus–Exposed, Uninfected Infants in Malawi: The BAN Study

Rodney J. Knight, M. Hudgens, L. Adair, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV-Exposed Infants in Uganda: Results From the First HIV Vaccine Trial in Infants in Africa

S. Gurunathan, M. Fowler, P. Musoke, 2013, Journal of acquired immune deficiency syndromes.

Decreasing HIV transmission through breastfeeding: moving from evidence to practice.

L. Guay, 2011, Journal of acquired immune deficiency syndromes.

Preventing Tuberculosis Among HIV-Infected Pregnant Women in Lesotho: The Case for Rolling Out Active Case Finding and Isoniazid Preventive Therapy

R. Chaisson, S. Kassaye, L. Guay, 2014, Journal of acquired immune deficiency syndromes.

Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women.

L. Guay, S. Eshleman, C. Ndugwa, 2000, AIDS research and human retroviruses.

Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant.

L. Guay, S. Eshleman, C. Ndugwa, 1999, AIDS research and human retroviruses.

Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.

N. Parkin, P. Musoke, Dana Jones, 2005, AIDS research and human retroviruses.

HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.

N. Parkin, D. Hoover, P. Musoke, 2007, AIDS research and human retroviruses.

Technical Advance Sensitivity of the ViroSeq HIV-1 Genotyping System for Detection of the K103N Resistance Mutation in HIV-1 Subtypes A, C, and D

J. Eshleman, D. Hoover, T. Taha, 2006 .

Implementation of Point-of-Care Diagnostics Leads to Variable Uptake of Syphilis, Anemia and CD4+ T-Cell Count Testing in Rural Maternal and Child Health Clinics

S. Kassaye, I. Jani, M. Temmerman, 2015, PloS one.

Mortality and Natural History Experience in Children of HIV-1 Infected Mothers in Uganda

D. Hom, L. Guay, K. Olness, 1993 .

Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.

D. Hom, L. Guay, L. Marum, 1996, Pediatric AIDS and HIV infection.

Mother-to-Child Transmission of HIV and HIV-Free Survival in Swaziland: A Community-Based Household Survey

G. Woelk, L. Guay, R. Machekano, 2018, AIDS and Behavior.

HIVNET NEVIRAPINE TRIALS. AUTHORS' REPLY

P. Lurie, S. Wolfe, M. Fowler, 1999 .

Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants.

L. Kasturi, L. Guay, J. Jackson, 1998, AIDS research and human retroviruses.

HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.

N. Parkin, D. Hoover, P. Musoke, 2007, AIDS research and human retroviruses.

Provision of Services and Care for HIV-Exposed Infants: A Comparison of Maternal and Child Health Clinic and HIV Comprehensive Care Clinic Models

J. Ong'ech, L. Guay, H. Hoffman, 2012, Journal of acquired immune deficiency syndromes.

Erratum: Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda (Aids (2002) 16 (1391-1400))

C. Fletcher, D. Hom, M. Fowler, 2002 .